The XIVth International HIV Drug Resistance Workshop, Quebec City, Canada, June 2005.
This report summarizes research advances that further our understanding of the evolution, mechanisms and clinical impact of HIV drug resistance presented at the XIVth International HIV Drug Resistance Workshop held in Quebec City, Canada from June 7-11, 2005. The topics that were discussed included the clinical implications of resistance in mother-to-child transmission, breakthroughs in technologies for studying resistance, resistance to new antiretroviral agents, mechanisms of HIV drug resistance, epidemiological trends, and HIV fitness and pathogenesis.
Boucher
Charles
C
University Hospital Utrecht, The Netherlands.
Larder
Brendan
B
Mellors
John
J
Richman
Douglas
D
D000818:Animals; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D004252:DNA Mutational Analysis / Q000379:methods; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics*; D006678:HIV / Q000201:enzymology / Q000235:genetics* / Q000472:pathogenicity; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000635:transmission; D016333:HIV Protease / Q000235:genetics; D054303:HIV Reverse Transcriptase / Q000235:genetics; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D009154:Mutation
D044966:Anti-Retroviral Agents; D054303:HIV Reverse Transcriptase; D016333:HIV Protease